Anyone have any knowledge or information on Motoneuronotrophic Factor (MNTF) - GM608? MNTF, developed by bio-company Genervon, is a specific, functional, regulatory, endogenous peptide for the protection of the nervous system from disorders and diseases including neurovascular and neurodegenerative diseases. They are currently clinically researching the drug for a variety of neurological diseases, including PD.

Columbia University has just begun recruiting for a Phase II study and are looking specifically for early stage PD patients. I'm considering joining the research study and will be speaking with the research team. In the interim, I would like to find out as much information as possible on MNTF, and GM608 in particular.

http://www.genervon.com/genervon/about.php